The trajectory of the erectile dysfunction drug presents a complex picture for investors. While the initial introduction generated massive returns, the expiration of its patent opened the door to cheaper alternatives, https://bookmarklinx.com/story21706118/sildenafil-and-the-pharmaceutical-industry-a-volatile-investment